Despite the relative lack of information on the efficacy and critical mechanisms of action of MC, our findings indicate that MC might be used as a potential therapeutic to improve HD-like symptoms by regulating the microglial STAT3 pathways. The gene discussed is STAT3; the disease is Huntington disease.